Vapreotide
 | |
| Clinical data | |
|---|---|
| Trade names | Sanvar |
| ATC code | H01CB04 (WHO) |
| Pharmacokinetic data | |
| Biological half-life | 30 minutes |
| Identifiers | |
| |
| Synonyms |
H-D-Phe-Cys(1)-Tyr-D-Trp-Lys-Val-Cys(1)-Trp-NH2 Octastatin |
| CAS Number | 103222-11-3 |
| PubChem (CID) | 23725064 |
| DrugBank | DB04894 |
| ChemSpider | 64425 |
| UNII | 2PK59M9GFF |
| KEGG | D06281 |
| Chemical and physical data | |
| Formula | C57H70N12O9S2 |
| Molar mass | 1131.37 g/mol |
| 3D model (Jmol) | Interactive image |
| Density | 1.4 g/cm3 |
| Boiling point | 1,540.9 °C (2,805.6 °F) |
| |
| |
Vapreotide (Sanvar) is a synthetic somatostatin analog. It is used in the treatment of esophageal variceal bleeding in patients with cirrhotic liver disease and AIDS-related diarrhea.[1]
It is an 8 residue peptide with sequence H-D-Phe-Cys(1)-Tyr-D-Trp-Lys-Val-Cys(1)-Trp-NH2.
References
This article is issued from Wikipedia - version of the 1/30/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.